Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Curr Med Chem. 2012;19(35):6072-9.
Salubrinal is a selective inhibitor of endoplasmic reticulum (ER) stress and affords remarkable protection to cardiomyocytes. By studying the structure-activity relationship (SAR) of salubrinal, it was found that modification of the quinoline ring terminus and thiourea unit could confer the compound PP1-24 with markedly enhanced cardioprotective activity (EC50 ≤ 0.3 μM) that is 50-fold more potent than salubrinal. Comparative molecular field analysis (CoMFA) was performed using the obtained biological data and resulted in a statistically significant CoMFA model with high predictive power (q2 = 0.741, r2 = 0.991).
沙利度胺是内质网(ER)应激的选择性抑制剂,能为心肌细胞提供显著的保护作用。通过研究沙利度胺的结构-活性关系(SAR),发现对喹啉环末端和硫脲单元进行修饰可以使化合物 PP1-24 具有显著增强的心脏保护活性(EC50≤0.3μM),比沙利度胺强 50 倍。使用获得的生物学数据进行比较分子场分析(CoMFA),得到了一个具有高预测能力的统计学上显著的 CoMFA 模型(q2=0.741,r2=0.991)。